Search results
FTC Challenges Patents on 20 Brand-Name Drugs as Chair Accuses Them of Inflating Prices with 'Bogus'...
Homenewshere.com· 15 hours agoThe Federal Trade Commission challenges patents on 20 brand-name drugs to spur competition, including the blockbuster weight-loss drug Ozempic. The FTC sent warning letters to 10 drugmakers alleging certain patents
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
CNBC· 2 days agoThe Federal Trade Commission on Tuesday said it is challenging hundreds of alleged "junk" patents...
ExxonMobil’s $60bn Pioneer acquisition nears FTC approval
Offshore Technology via Yahoo Finance· 3 hours agoThe US Federal Trade Commission's (FTC) nod is expected following an agreement that Pioneer's...
Williams-Sonoma to pay $3.2M for violating FTC’s Made in USA order
Retail Dive via Yahoo Finance· 23 hours ago“Williams-Sonoma’s deception misled consumers and harmed honest American businesses,” FTC Chair Lina...
Analysis of FTC Non-Compete Ban Legal Challenges: Does the Ban Pass Constitutional Muster? (And...
JD Supra· 14 hours agoOn April 23, 2024, the Federal Trade Commission (FTC) voted in a 3 to 2 decision along party lines to adopt its Final Non-Compete Clause Rule (“Noncompete Rule”) banning post-employment ...
Exxon Set to Win FTC Approval for $60 Billion Pioneer Deal
Bloomberg via Yahoo Finance· 12 hours ago(Bloomberg) -- The US Federal Trade Commission is poised to greenlight Exxon Mobil Corp.’s $60...
Biden administration tells employers to stop shackling workers with ‘noncompete agreements’
The Conversation via Yahoo News· 7 days agoMladen Antonov/AFP via Getty Images Noncompetes and low-wage workers FTC chair Lina Khan has...
Ruling banning non-compete clauses is challenged in court
The Post-Standard· 3 days agoLabor proponents including the AFL-CIO have long disliked these employment clauses, saying it...
FTC cracks down on drugmaker patents, including Novo's Ozempic; analysts weigh in
Investing.com· 2 days agoFTC cracks down on drugmaker patents, including Novo's Ozempic; analysts weigh in
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 2 days ago“By filing bogus patent listings, pharma companies block competition and inflate the cost of...